Applied Clinical Trials: Small Biopharma and CROs: Seeking Stronger Synergies

September 28, 2020

Many emerging biopharmaceutical companies hire contract research organizations (CROs) because of limited staffing and regulatory experience to help them navigate the regulatory pathway. CROs are instrumental in helping these biopharma overcome obstacles such as clinical trial timeline delays, out-of-scope change orders and cost overruns, especially for smaller biotech companies who cannot afford drastic missteps.

All of the above highlight the need to find a CRO that will be the right fit and consistently responsive to clients’ needs.

To propel the biotech companies we partner with, TD2 utilizes a “value-add” approach, where we strive to supplement their capabilities while filling in the gaps in the internal infrastructure to help develop their plan and process every step of the way.

Hear from TD2 president and CEO, Stephen Gately, and chief operating officer, Tara Frank, about how TD2 uses their suite of capabilities to maximize the CRO and emerging biopharma relationship in this recent Applied Clinical Trials article.

A Translational Lens on Synergistic Cancer Therapy: Insights from Our Recent Case Study

In cancer drug development, monotherapies often lose ground when tumors adapt. This is especially true for KRASmutant non–small cell lung cancers ...

Read more +

Redesigning Preclinical Oncology: A Framework for Improving Clinical Translatability with AI, RECIST-Inspired Metrics, and Systems-Level Thinking

Despite decades of investment in oncology drug development, the translational pipeline from preclinical models to clinical success remains ...

Read more +

Radiopharmaceutical Dosing Under FDA’s New Spotlight: What You Should Know

The FDA has issued a new draft guidance titled “Oncology Therapeutic Radiopharmaceuticals: Dosage Optimization During Clinical Development.” This ...

Read more +

Get Started

Contact Us Today!

If you’re looking for an expert team to guide your trial with efficiency in mind, we can help. As the creators of the Dynamic Trial, TD2 provides start-to-finish support with trial strategy, design and execution for faster go-to-market potential.